CPMV Share Price Performance
US$0.50
-0.50 (-50.20%)
Price US$0.50
Share PriceUS$0.50
CPMV Community Narratives
There are no narratives available yet.
Recent CPMV News & Updates
Mosaic ImmunoEngineering, Inc. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.096
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- -22.8%
Mosaic ImmunoEngineering, Inc. Competitors
Snowflake Analysis
About CPMV
- Founded
- 2020
- Employees
- 5
- CEO
- WebsiteView website
Mosaic ImmunoEngineering, Inc., a development-stage biotechnology company, focuses on advancing and commercialization of immunotherapies for the treatment of cancer. It engages in pursuing new product candidates and platforms to build a new pipeline based on immunotherapies. Mosaic ImmunoEngineering, Inc. was founded in 2020 and is based in Huntington Beach, California.
Market Insight
Market sentiment on BTC treasury companies is moving, and with volatility rising, disagreements over their future prospects are as heated as ever.
Continue reading
U.S. Market Performance
- 7 Days: -1.6%
- 3 Months: 9.8%
- 1 Year: 15.1%
- Year to Date: 8.0%
Over the last 7 days, the market has dropped 1.6%, driven by a decline of 3.6% in the Information Technology sector. As for the longer term, the market has actually risen by 15% in the last year. Looking forward, earnings are forecast to grow by 15% annually. Market details ›